TFF Pharmaceuticals Inc - Co and Leidos to Advance Next-Generation Biodefense Countermeasures Under Darpa PPB Program Into Preclinical Testing
TFF Pharmicals Inc-Co和Leidos將DARPA PPB計劃下的下一代生物防禦對策推進到臨床前測試
TFF Pharmaceuticals Inc - Co and Leidos to Advance Next-Generation Biodefense Countermeasures Under Darpa PPB Program Into Preclinical Testing
TFF Pharmicals Inc-Co和Leidos將DARPA PPB計劃下的下一代生物防禦對策推進到臨床前測試
譯文內容由第三人軟體翻譯。